bluuebunny/crossref_metadata_2025 huggingface dataset:
Subjective Impression of an Office with Biophilic Design and Blue Lighting: A Pilot Study
Authors: Xie Jiarong , Sawyer Azadeh Omidfar , Ge Siqing , Li Tian
Published: December 2022

This paper investigates and compares people’s subjective impression of an office with a biophilic design and blue lighting. Existing studies have examined their influence on perception separately, but how they compare is unclear. Additionally, only a few studies have used an office setting as a case study. To address this research gap, this study collected people’s ratings and rankings of four simulated interior scenes of a private office using an online survey. The scenes include blue lighting, a biophilic design with daylight and view, a biophilic design with indoor plants, and a non-biophilic baseline with conventional white lighting. A total of 284 complete responses were collected and analyzed using a mixed-effect model. It was found that the two biophilic designs improved people’s perception of the office compared to the base case. The biophilic design with access to daylight and view outperformed the space with indoor plants in all the examined perceptual categories, specifically how the office space was perceived by participants as brighter, more comfortable, and spacious. On the contrary, the space with blue lighting decreased people’s ratings in most perceptual attributes in comparison to the baseline. The negative influence was notably significant in how lively, comfortable, bright, and appealing the space was perceived as being by participants. Subjects’ preference rankings of the four simulated office spaces showed a similar pattern.
Crack45K: Integration of Vision Transformer with Tubularity Flow Field (TuFF) and Sliding-Window Approach for Crack-Segmentation in Pavement Structures
Authors: Ali Luqman , Jassmi Hamad Al , Khan Wasif , Alnajjar Fady
Published: December 2022

Recently, deep-learning (DL)-based crack-detection systems have proven to be the method of choice for image processing-based inspection systems. However, human-like generalization remains challenging, owing to a wide variety of factors such as crack type and size. Additionally, because of their localized receptive fields, CNNs have a high false-detection rate and perform poorly when attempting to capture the relevant areas of an image. This study aims to propose a vision-transformer-based crack-detection framework that treats image data as a succession of small patches, to retrieve global contextual information (GCI) through self-attention (SA) methods, and which addresses the CNNs’ problem of inductive biases, including the locally constrained receptive-fields and translation-invariance. The vision-transformer (ViT) classifier was tested to enhance crack classification, localization, and segmentation performance by blending with a sliding-window and tubularity-flow-field (TuFF) algorithm. Firstly, the ViT framework was trained on a custom dataset consisting of 45K images with 224 × 224 pixels resolution, and achieved accuracy, precision, recall, and F1 scores of 0.960, 0.971, 0.950, and 0.960, respectively. Secondly, the trained ViT was integrated with the sliding-window (SW) approach, to obtain a crack-localization map from large images. The SW-based ViT classifier was then merged with the TuFF algorithm, to acquire efficient crack-mapping by suppressing the unwanted regions in the last step. The robustness and adaptability of the proposed integrated-architecture were tested on new data acquired under different conditions and which were not utilized during the training and validation of the model. The proposed ViT-architecture performance was evaluated and compared with that of various state-of-the-art (SOTA) deep-learning approaches. The experimental results show that ViT equipped with a sliding-window and the TuFF algorithm can enhance real-world crack classification, localization, and segmentation performance.
Understanding the Contribution of Lactate Metabolism in Cancer Progress: A Perspective from Isomers
Authors: Cai Ming , Wan Jian , Cai Keren , Song Haihan , Wang Yujiao , Sun Wanju , Hu Jingyun
Published: December 2022

Lactate mediates multiple cell-intrinsic effects in cancer metabolism in terms of development, maintenance, and metastasis and is often correlated with poor prognosis. Its functions are undertaken as an energy source for neighboring carcinoma cells and serve as a lactormone for oncogenic signaling pathways. Indeed, two isomers of lactate are produced in the Warburg effect: L-lactate and D-lactate. L-lactate is the main end-production of glycolytic fermentation which catalyzes glucose, and tiny D-lactate is fabricated through the glyoxalase system. Their production inevitably affects cancer development and therapy. Here, we systematically review the mechanisms of lactate isomers production, and highlight emerging evidence of the carcinogenic biological effects of lactate and its isomers in cancer. Accordingly, therapy that targets lactate and its metabolism is a promising approach for anticancer treatment.
Meta-Analysis of Pharmacological, Nutraceutical and Phytopharmaceutical Interventions for the Treatment of Cancer Related Fatigue
Authors: Yennurajalingam Sriram , Lu Zhanni , Rozman De Moraes Aline , Tull Nhu Nhu , Kubiak Michal J. , Geng Yimin , Andersen Clark R. , Bruera Eduardo
Published: December 2022

Purpose: In this study we aimed to estimate the effectiveness of pharmacological, nutraceutical, and phytopharmaceutical treatments on CRF. Methods: Ovid MEDLINE, Ovid Embase, Ovid Psych info, CINHAHL and Cochrane Library databases were searched up to 30 September 2021. Randomized controlled trials of pharmacological, nutraceutical and phytopharmaceutical interventions for treatment of CRF for at least one week duration and have used valid tool to assess severity of CRF as a primary or secondary outcome were considered. Results: 32 eligible studies (4896 patients) were reviewed. For the overall meta-analysis, the random effect models yielded the treatment effect (95% CI) of −0.29 (−0.48,−0.09), p < 0.001. The meta-analysis did not show significant reduction of CRF with treatment with ginseng (n = 6), guarana (n = 3), megestrol (n = 2), mistletoe (n = 3), psychostimulants (n = 14), SSRI/antidepressants (n = 2). Corticosteroids (n = 2) showed significant reduction in CRF with treatment effects of 0.94 (−1.21, −0.67), p <0.0001, respectively. Conclusions: In this study, overall meta-analysis of all studies demonstrates significant reduction of CRF using Pharmacological, Nutraceutical and Phytopharmaceutical interventions with a pooled standardized treatment effect of −0.29. Metanalysis of Corticosteroids studies showed significant reduction in CRF. Further studies are needed.
Free and Poly-Methyl-Methacrylate-Bounded BODIPYs: Photodynamic and Antimigratory Effects in 2D and 3D Cancer Models
Authors: Ballestri Marco , Marras Emanuela , Caruso Enrico , Bolognese Fabrizio , Malacarne Miryam Chiara , Martella Elisa , Tubertini Matilde , Gariboldi Marzia Bruna , Varchi Greta
Published: December 2022

Several limitations, including dark toxicity, reduced tumor tissue selectivity, low photostability and poor biocompatibility hamper the clinical use of Photodynamic therapy (PDT) in cancer treatment. To overcome these limitations, new PSs have been synthetized, and often combined with drug delivery systems, to improve selectivity and reduce toxicity. In this context, BODIPYs (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) have recently emerged as promising and easy-to-handle scaffolds for the preparation of effective PDT antitumor agents. In this study, the anticancer photodynamic effect of newly prepared negatively charged polymethyl methacrylate (nPMMA)-bounded BODIPYs (3@nPMMA and 6@nPMMA) was evaluated on a panel of 2D- and 3D-cultured cancer cell lines and compared with free BODIPYs. In particular, the effect on cell viability was evaluated, along with their ability to accumulate into the cells, induce apoptotic and/or necrotic cell death, and inhibit cellular migration. Our results indicated that 3@nPMMA and 6@nPMMA reduce cancer cell viability in 3D models of HC116 and MCF7 cells more effectively than the corresponding free compounds. Importantly, we demonstrated that MDA-MB231 and SKOV3 cell migration ability was significantly impaired by the PDT treatment mediated by 3@nPMMA and 6@nPMMA nanoparticles, likely indicating the capability of this approach to reduce metastatic tumor potential.
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
Authors: Byskata Karin , Lukoseviciute Monika , Tuti Filippo , Zupancic Mark , Kostopoulou Ourania N. , Holzhauser Stefan , Dalianis Tina
Published: December 2022

Human papillomavirus positive (HPV+) tonsillar and base of tongue cancer (TSCC/BOTSCC) is rising in incidence, but chemoradiotherapy is not curative for all. Therefore, targeted therapy with PI3K (BYL719), PARP (BMN-673), and WEE1 (MK-1775) inhibitors alone or combined was pursued with or without 10 Gy and their effects were analyzed by viability, proliferation, and cytotoxicity assays on the TSCC/BOTSCC cell lines HPV+ UPCI-SCC-154 and HPV− UT-SCC-60A. Effective single drug/10 Gy combinations were validated on additional TSCC lines. Finally, APR-246 was assessed on several TSCC/BOTSCC cell lines. BYL719, BMN-673, and MK-1775 treatments induced dose dependent responses in HPV+ UPCI-SCC-154 and HPV− UT-SCC-60A and when combined with 10 Gy, synergistic effects were disclosed, as was also the case upon validation. Using BYL719/BMN-673, BYL719/MK-1775, or BMN-673/MK-1775 combinations on HPV+ UPCI-SCC-154 and HPV− UT-SCC-60A also induced synergy compared to single drug administrations, but adding 10 Gy to these synergistic drug combinations had no further major effects. Low APR-246 concentrations had limited usefulness. To conclude, synergistic effects were disclosed when complementing single BYL719 BMN-673 and MK-1775 administrations with 10 Gy or when combining the inhibitors, while adding 10 Gy to the latter did not further enhance their already additive/synergistic effects. APR-246 was suboptimal in the present context.
Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study
Authors: Liao Yen-Hsiang , Hsu Ren-Jun , Wang Tzu-Hwei , Wu Chen-Ta , Huang Sheng-Yao , Hsu Chung-Y. , Hsu Wen-Lin , Liu Dai-Wei
Published: December 2022

Ischemic cardiac or cerebrovascular disease (ICCD) survivors represent a subpopulation with a high cancer risk. Antiplatelet medications, such as aspirin, remain a fundamental therapy for the secondary prevention of ischemic attack in these patients. We conducted a population-based cohort study to investigate the association of long-term low-dose aspirin use with the risk of primary cancer in ICCD survivors. Patients aged ≥20 years with newly diagnosed ICCD (n = 98,519) between January 2000 and December 2013 were identified from the Taiwan National Health Insurance Research Database. The aspirin user and nonuser groups (each n = 24,030) were propensity-matched (1:1) for age, sex, comorbidities, prior medications, ICCD diagnosis year, and year of index dates. The incidence rate of primary cancer was significantly lower in the user group (6.49/1000 person-years) than in the nonuser group (14.04/1000 person-years). Multivariate Cox regression analysis indicated that aspirin use was an independent factor associated with a reduced risk of primary cancer (aHR (95% confidence interval) = 0.42 (0.38–0.45)) after adjustment. Kaplan–Meier curve analysis revealed that the cumulative incidence rate of primary cancer was significantly lower (p < 0.0001) in the user group than in the nonuser group over the 14-year follow-up period. Subgroup analyses demonstrated that this anticancer effect increased with duration of treatment and with similar estimates in women and men. In addition, aspirin use was associated with a reduced risk for seven out of the ten most common cancers in Taiwan. These findings suggest the anticancer effect of aspirin in ICCD survivors and provide information for assessing the benefit-to-risk profile of aspirin as an antiplatelet medication in these patients.
Perioperative Blood Transfusion Is Dose-Dependently Associated with Cancer Recurrence and Mortality after Head and Neck Cancer Surgery
Authors: Hee Hui-Zen , Chang Kuang-Yi , Huang Chii-Yuan , Chang Wen-Kuei , Tsou Mei-Yung , Lin Shih-Pin
Published: December 2022

Background: The association between perioperative blood transfusion and cancer prognosis in patients with head and neck cancer (HNC) receiving surgery remains controversial. Methods: We designed a retrospective observational study of patients with HNC undergoing tumor resection surgery from 2014 to 2017 and followed them up until June 2020. An inverse probability of treatment weighting (IPTW) was applied to balance baseline patient characteristics in the exposed and unexposed groups. COX regression was used for the evaluation of tumor recurrence and overall survival. Results: A total of 683 patients were included; 192 of them (28.1%) received perioperative packed RBC transfusion. Perioperative blood transfusion was significantly associated with HNC recurrence (IPTW adjusted HR: 1.37, 95% CI: 1.1–1.7, p = 0.006) and all-cause mortality (IPTW adjusted HR: 1.37, 95% CI: 1.07–1.74, p = 0.011). Otherwise, there was an increased association with cancer recurrence in a dose-dependent manner. Conclusion: Perioperative transfusion was associated with cancer recurrence and mortality after HNC tumor surgery.
Merkel Cell Carcinoma—Update on Diagnosis, Management and Future Perspectives
Authors: Zaggana Eleni , Konstantinou Maria Polina , Krasagakis Gregor Herrmann , de Bree Eelco , Kalpakis Konstantinos , Mavroudis Dimitrios , Krasagakis Konstantinos
Published: December 2022

MCC is a rare but highly aggressive skin cancer. The identification of the driving role of Merkel cell polyomavirus (MCPyV) and ultraviolet-induced DNA damage in the oncogenesis of MCC allowed a better understanding of its biological behavior. The presence of MCPyV-specific T cells and lymphocytes exhibiting an ‘exhausted’ phenotype in the tumor microenvironment along with the high prevalence of immunosuppression among affected patients are strong indicators of the immunogenic properties of MCC. The use of immunotherapy has revolutionized the management of patients with advanced MCC with anti-PD-1/PD L1 blockade, providing objective responses in as much as 50–70% of cases when used in first-line treatment. However, acquired resistance or contraindication to immune checkpoint inhibitors can be an issue for a non-negligible number of patients and novel therapeutic strategies are warranted. This review will focus on current management guidelines for MCC and future therapeutic perspectives for advanced disease with an emphasis on molecular pathways, targeted therapies, and immune-based strategies. These new therapies alone or in combination with anti-PD-1/PD-L1 inhibitors could enhance immune responses against tumor cells and overcome acquired resistance to immunotherapy.
Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells
Authors: Oh Jun Y. , Osorio Robert C. , Jung Jangham , Carrete Luis , Choudhary Nikita , Lad Meeki , Saha Atul , Aghi Manish K.
Published: December 2022

The pituitary gland is one of the most cellularly diverse regions of the brain. Recent advancements in transcriptomic biology, such as single-cell RNA sequencing, bring an unprecedented glimpse into the molecular composition of the pituitary, both in its normal physiological state and in disease. Deciphering the normal pituitary transcriptomic signatures provides a better insight into the ontological origin and development of five types of endocrine cells, a process involving complex cascades of transcription factors that are still being established. In parallel with these observations about normal pituitary development, recent transcriptomic findings on pituitary neuroendocrine tumors (PitNETs) demonstrate both preservations and changes in transcription factor expression patterns compared to those seen during gland development. Furthermore, recent studies also identify differentially expressed genes that drive various tumor behaviors, including hormone hypersecretion and tumor aggression. Understanding the comprehensive multiomic profiles of PitNETs is essential in developing molecular profile-based therapies for PitNETs not curable with current treatment modalities and could eventually help align PitNETs with the breakthroughs being made in applying precision medicine to other tumors.
Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions
Authors: Kaur Kawaljit , Jewett Anahid
Published: December 2022

There is significant interest and debate regarding the best mouse model of human disease, since studies in wild-type mice may not always recapitulate human diseases. The NSG mouse model has been one of the most commonly used mouse models to study cancer; however, this mouse model, even though it has several advantages in regard to the ease of tumor implantation and financial feasibility, does not represent human disease due to the immunodeficient nature of this model. In this study, we performed oral and pancreatic tumor studies in NSG and hu-BLT mice and found several distinguishing features that make hu-BLT model more suitable for studying human cancer. In addition, we compared the immune function of humans to hu-BLT mice to understand the differences and similarities of the models. Oral and pancreatic cancer stem cells were implanted in NSG and hu-BLT mice. Both tumors grew robustly in NSG mice and killed them within a short period of time. On the contrary, unlike NSG mice, tumor-bearing hu-BLT mice survived longer, grew smaller tumors, and the grown tumors exhibited lower rates of expansion, with a higher surface expression of MHC-class I and lower NK cell-mediated cytotoxicity that was previously shown to have more of a differentiated phenotype. Although the peripheral blood of hu-BLT mice in comparison to that of humans had lower percentages of NK cells and cytotoxic function, it mediated a higher secretion of IFN-γ, likely contributing to the differentiation of the tumor cells and subsequent decrease in the tumor size in the hu-BLT mice in comparison to the NSG mice. Spleen-derived hu-BLT mouse NK cells were able to expand in the presence of autologous osteoclasts and substantially increase both cytotoxicity and secretion of IFN-γ, similar to those seen in peripheral blood-derived human NK cells, indicating that NK cells from hu-BLT mice are capable of expansion and functional activation when activating signals are given. Thus, the many similarities between human and hu-BLT mouse immune systems make this mouse model more appropriate to study human cancer. In particular, it is well-suited for studies of allogeneic NK cell-based immunotherapy in cancer treatment. The advantages and challenges of hu-BLT mice in cancer studies are also discussed in this report.
CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
Authors: Włodarczyk Marta , Pyrzynska Beata
Published: December 2022

Chimeric antigen receptor (CAR)-modified T cell therapy has been rapidly developing in recent years, ultimately revolutionizing immunotherapeutic strategies and providing significant anti-tumor potency, mainly in treating hematological neoplasms. However, graft-versus-host disease (GVHD) and other adverse effects, such as cytokine release syndromes (CRS) and neurotoxicity associated with CAR-T cell infusion, have raised some concerns about the broad application of this therapy. Natural killer (NK) cells have been identified as promising alternative platforms for CAR-based therapies because of their unique features, such as a lack of human leukocyte antigen (HLA)-matching restriction, superior safety, and better anti-tumor activity when compared with CAR-T cells. The lack of CRS, neurotoxicity, or GVHD, in the case of CAR-NK therapy, in addition to the possibility of using allogeneic NK cells as a CAR platform for “off-the-shelf” therapy, opens new windows for strategic opportunities. This review underlines recent design achievements in CAR constructs and summarizes preclinical studies’ results regarding CAR-NK therapies’ safety and anti-tumor potency. Additionally, new approaches in CAR-NK technology are briefly described, and currently registered clinical trials are listed.
Microbiome Profiling from Fecal Immunochemical Test Reveals Microbial Signatures with Potential for Colorectal Cancer Screening
Authors: Khannous-Lleiffe Olfat , Willis Jesse R. , Saus Ester , Moreno Victor , Castellví-Bel Sergi , Gabaldón Toni ,   on behalf of the CRIPREV Consortium
Published: December 2022

Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer deaths worldwide. Early diagnosis of CRC, which saves lives and enables better outcomes, is generally implemented through a two-step population screening approach based on the use of Fecal Immunochemical Test (FIT) followed by colonoscopy if the test is positive. However, the FIT step has a high false positive rate, and there is a need for new predictive biomarkers to better prioritize cases for colonoscopy. Here we used 16S rRNA metabarcoding from FIT positive samples to uncover microbial taxa, taxon co-occurrence and metabolic features significantly associated with different colonoscopy outcomes, underscoring a predictive potential and revealing changes along the path from healthy tissue to carcinoma. Finally, we used machine learning to develop a two-phase classifier which reduces the current false positive rate while maximizing the inclusion of CRC and clinically relevant samples.
Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
Authors: Zhang Huina , Peng Yan
Published: December 2022

HER2-low breast cancer (BC) is a newly defined subset of HER2-negative BC that has HER2 immunohistochemical (IHC) score of 1+ or score of 2+/in situ hybridization (ISH) negative phenotype. Recent clinical trials have demonstrated significant clinical benefits of novel HER2 directing antibody-drug conjugates (ADCs) in treating this group of tumors. Trastuzumab-deruxtecan (T-Dxd), a HER2-directing ADC was recently approved by the U.S. Food and Drug Administration as the first targeted therapy to treat HER2-low BC. However, HER2-low BC is still not well characterized clinically and pathologically. This review aims to update the current biological, pathological and clinical landscape of HER2-low BC based on the English literature published in the past two years and to propose the future directions on clinical management, pathology practice, and translational research in this subset of BC. We hope it would help better understand the tumor biology of HER2-low BC and the current efforts for identifying and treating this newly recognized targetable group of BC.
Oxidative Drugs and microRNA: New Opportunities for Cancer Prevention
Authors: Izzotti Alberto
Published: December 2022

Despite the impressive progress of therapies in recent years, cancer still remains the second leading cause of death in developed countries [...]
Titanium Dioxide as the Most Used Photocatalyst for Water Purification: An Overview
Authors: Armaković Sanja J. , Savanović Maria M. , Armaković Stevan
Published: December 2022

Titanium dioxide (TiO2), one of the most frequently used materials in general, has emerged as an excellent photocatalytic material for environmental applications. In this review, principles and mechanisms of the photocatalytic activity of TiO2 have been analyzed. Structural and physical specificities of TiO2 nanoparticles, such as morphology, crystal structure, and electronic and optical properties, have been considered in the context of photocatalytic applications. A review of the influence of several factors, such as the type and dimensions of photocatalyst particles, pH of the solution, the influence of oxidants/electron acceptors, and light intensity on photocatalytic properties of TiO2, has been provided. Superhydrophilicity as an intrinsic property of the TiO2 surface was discussed through surface reconstruction on TiO2 during the reversible hydrophilic changes. Additionally, attention was paid to improving the photocatalytic properties of TiO2 particles through aggregation and agglomeration.
Synthesis of a SiO2/Co(OH)2 Nanocomposite Catalyst for SOX/NOX Oxidation in Flue Gas
Authors: Khabra Alon , Cohen Haim , Pinhasi Gad A. , Querol Xavier , Córdoba Sola Patricia , Zidki Tomer
Published: December 2022

Sulfur and nitrogen oxides (SOX/NOX) are the primary air toxic gas pollutants emitted during fuel combustion, causing health and environmental concerns. Therefore, their emission in flue gases is strictly regulated. The existing technologies used to decrease SOX/NOX content are flue gas desulfurization, which necessitates high capital and operating costs, and selective catalytic reduction, which, in addition to these costs, requires expensive catalysts and high operating temperatures (350–400 °C). New wet scrubbing processes use O3 or H2O2 oxidants to produce (NH4)2SO4 and NH4NO3 fertilizers upon ammonia injection. However, these oxidants are expensive, corrosive, and hazardous. SiO2/Co(OH)2 nanocomposites are presented here as potential catalysts for SOX/NOX oxidation in wet scrubber reactors to scrub these toxic gases using atmospheric oxygen as the oxidant at relatively low temperatures of 60–90 °C. Several silica-cobalt-oxide-based nanocomposites were synthesized as potential catalysts at different concentrations and temperatures. The nanocomposite catalysts were characterized and exhibited excellent catalytic properties for SOX/NOX oxidation using atmospheric oxygen as the oxidant, replacing the problematic H2O2/O3. We thus propose SiO2-supported Co(OH)2 nanoparticles (NPs) as excellent catalysts for the simultaneous scrubbing of polluting SOX/NOX gases in flue gases using atmospheric O2 as the oxidation reagent at a relatively low-temperature range.
The Pincer Ligand Supported Ruthenium Catalysts for Acetylene Hydrochlorination: Molecular Mechanisms from Theoretical Insights
Authors: Wang Xingtao , Zhao Jiangshan , Li Yongwang , Zhang Xubin , Wang Fumin , Wu Botao , Wang Tian
Published: December 2022

Pincer ligand supported RuII chloride complexes may be used for acetylene hydrochlorination as non-mercury molecular catalysts. Based on theoretical calculations, the catalytic mechanism and the interaction between catalysts and reactants has been evaluated, indicating that the (pincer)RuIICl2 platform supports electrophilic proton-ruthenation of C2H2. Energy decomposition studies further illustrate the electron-rich property of the RuII center, which can increase the negative charge of C2H2 via 4d-electron backdonation. Thus, the electrophilic reaction mechanism is favored due to lower energetic barriers. By improving the electron-donating ability of ligands, this lowering of energetic barriers can be enhanced. Therefore, non-mercury catalysts for acetylene hydrochlorination with milder reaction conditions and higher catalytic activity can be designed.
Au@CdS Nanocomposites as a Visible-Light Photocatalyst for Hydrogen Generation from Tap Water
Authors: Lin Ying-Ru , Chang Yu-Cheng , Chiao Yung-Chang , Ko Fu-Hsiang
Published: December 2022

The Au@CdS nanocomposites have been synthesized using a combination of wet chemical and hydrothermal approaches at lower reaction temperatures. The concentrations of CdS precursors and reaction temperature can be essential in influencing photocatalytic water splitting under blue-LED light excitation. The optimized Au@CdS nanocomposites (5 mM CdS precursors and 100 °C) exhibited the highest hydrogen evolution rate of 1.041 mmolh−1 g−1, which is 175.3 times higher than CdS nanoparticles for de-ionized water under blue-LED light excitation. This result is ascribed to separate photogenerated charge carriers and increased light absorption by the Au core. The Au@CdS nanocomposites (1.204 mmolh−1 g−1) revealed significant applications in photocatalytic tap water splitting under blue-LED light excitation, which is 512.3 times higher than CdS nanoparticles. In addition, reusability experiments demonstrate that Au@CdS nanocomposites exhibit excellent stability for the long-term photocatalytic tap water splitting process. Furthermore, this research shows that Au nanoparticles decorated with CdS shells effectively achieve high-efficiency conversion from light to hydrogen energy.
Synthesis of Silicotungstic Acid/Ni-Zr-O Composite Nanoparticle by Using Bimetallic Ni-Zr MOF for Fatty Acid Esterification
Authors: Zhang Qiuyun , Hu Mengmeng , Wang Jialu , Lei Yanting , Wu Yaping , Liu Qing , Zhao Yongting , Zhang Yutao
Published: December 2022

In this study, the bimetallic Ni-Zr MOF-derived nickel-zirconium oxide (Ni-Zr-O)-impregnated silicotungstic acid (HSiW) nanocomposite catalyst (HSiW@Ni-Zr-O) was prepared via a hydrothermal procedure followed by a pyrolysis treatment, and its structural, morphological, and surface components and oxidation states were characterized by using XRD, FTIR, TPD-NH3, SEM, TEM, N2 physisorption, and XPS analyses. Then, the nanocomposite catalysts were successfully applied to the esterification of oleic acid (OA) with methanol. According to its characteristics, the obtained HSiW@Ni-Zr-O-1 catalyst would generate larger pores, a higher acidity, and active interfaces at the calcining temperature of 300 °C. Therefore, HSiW@Ni-Zr-O-1 exhibits an excellent catalytic activity of 95.2% under optimal reaction conditions. Additionally, the catalyst can be reused with a good catalytic activity after nine cycles. This study highlights the opportunity of using bimetallic MOFs as precursors to the synthesis of highly nanoporous metal oxide, which supports the larger-industrial scale production of biofuels.
Photocatalytic Degradation of Organic Dyes Contaminated Aqueous Solution Using Binary CdTiO2 and Ternary NiCdTiO2 Nanocomposites
Authors: Khan Shakeel , Noor Awal , Khan Idrees , Muhammad Mian , Sadiq Muhammad , Muhammad Niaz
Published: December 2022

The synergistic effect of binary CdTiO2 and ternary NiCdTiO2 on the photocatalytic efficiency of TiO2 nanoparticles was investigated. The SEM analysis demonstrates spherical TiO2 NPs of different sizes present in agglomerated form. The structural analysis of the nanocomposites reveals a porous structure for TiO2 with well deposited Cd and Ni NPs. TEM images show NiCdTiO2 nanocomposites as highly crystalline particles having spherical and cubical geometry with an average particle size of 20 nm. The EDX and XRD analysis confirm the purity and anatase phase of TiO2, respectively. Physical features of NiCdTiO2 nanocomposite were determined via BET analysis which shows that the surface area, pore size and pore volume are 61.2 m2/g, 10.6 nm and 0.1 cm3/g, respectively. The absorbance wavelengths of the CdTiO2 and NiCdTiO2 nanocomposites have shown red shift as compared to the neat TiO2 due to coupling with Ni and Cd that results in the enhanced photocatalytic activity. The photocatalytic activity demonstrated that TiO2, CdTiO2 and NiCdTiO2 degrade methylene blue (MB) and methyl green (MG) about 76.59, 82, 86% and 63.5, 88, 97.5%, respectively, at optimum reaction conditions.
Advances in the Clinical Application of Histamine and Diamine Oxidase (DAO) Activity: A Review
Authors: Tan Zhaowang , Ou Yingwei , Cai Wenwei , Zheng Yueliang , Li Hengjie , Mao Yunyun , Zhou Shengang , Tu Jianfeng
Published: December 2022

The serum level of diamine oxidase (DAO) reflects the integrity and maturation of the small intestinal mucosa. This measure is important in diagnosing various diseases, including chronic urticaria tachyphylaxis, multiple organ dysfunction syndrome, preterm abortion, and migraine. This review aimed to summarize the findings of previous studies on the changes in DAO levels in diverse diseases and the application of this enzyme in the clinical setting, as well as the roles of this enzyme under physiological and pathological conditions. The advances in the mechanism and clinical application of DAO presented in this review will contribute to a better understanding of this enzyme and open up new and broader perspectives for future basic research and clinical applications.
Chemoenzymatic Protocol for the Synthesis of Enantiopure β-Blocker (S)-Bisoprolol
Authors: Bocquin Lucas , Jacobsen Elisabeth Egholm
Published: December 2022

The β-blocker (S)-bisoprolol hemifumarate has been synthesised in 96% enantiomeric excess with 19% total yield in a six-step synthesis. A transesterification reaction of the racemic chlorohydrin 1-chloro-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol catalysed by lipase B from Candida antarctica resulted in the R-chlorohydrin in high enantiomeric purity. Reaction of this building block with isopropylamine in methanol gave (S)-bisoprolol, and further reaction with fumaric acid gave (S)-bisoprolol fumarate in 96% ee. Specific rotation value confirmed the absolute configuration of the enantiopure drug.
Myostatin Mutation Enhances Bovine Myogenic Differentiation through PI3K/AKT/mTOR Signalling via Removing DNA Methylation of RACK1
Authors: Zhao Yiping , Xia Xiaoxia , Wang Qiaomeng , Hu Debao , Zhang Linlin , Li Xin , Ding Xiangbin , Guo Hong , Guo Yiwen
Published: December 2022

Myostatin (MSTN) is a negative regulator of skeletal muscle development and plays an important role in muscle development. Fluctuations in gene expression influenced by DNA methylation are critical for homeostatic responses in muscle. However, little is known about the mechanisms underlying this fluctuation regulation and myogenic differentiation of skeletal muscle. Here we report a genome-wide analysis of DNA methylation dynamics in bovine skeletal muscle myogenesis after myostatin editing. We show that, after myostatin editing, an increase in TETs (DNA demethylases) and a concomitant increase in the receptor for activated C kinase 1 (RACK1) control the myogenic development of skeletal muscle. Interestingly, enhancement of PI3K/AKT/mTOR signaling by RACK1 appears to be an essential driver of myogenic differentiation, as it was associated with an increase in myogenic differentiation marker factors (MyHC and MyoG) during muscle differentiation. Overall, our results suggest that loss of myostatin promotes the myogenic differentiation response in skeletal muscle by decreasing DNA methylation of RACK1.
Cell Dome as an Evaluation Platform for Organized HepG2 Cells
Authors: Kazama Ryotaro , Fujita Satoshi , Sakai Shinji
Published: December 2022

Human-hepatoblastoma-derived cell line, HepG2, has been widely used in liver and liver cancer studies. HepG2 spheroids produced in a three-dimensional (3D) culture system provide a better biological model than cells cultured in a two-dimensional (2D) culture system. Since cells at the center of spheroids exhibit specific behaviors attributed to hypoxic conditions, a 3D cell culture system that allows the observation of such cells using conventional optical or fluorescence microscopes would be useful. In this study, HepG2 cells were cultured in “Cell Dome”, a micro-dome in which cells are enclosed in a cavity consisting of a hemispherical hydrogel shell. HepG2 cells formed hemispherical cell aggregates which filled the cavity of Cell Domes on 18 days of culture and the cells could continue to be cultured for 29 days. The cells at the center of hemispherical cell aggregates were observed using a fluorescence microscope. The cells grew in Cell Domes for 18 days exhibited higher Pi-class Glutathione S-Transferase enzymatic activity, hypoxia inducible factor-1α gene expression, and higher tolerance to mitomycin C than those cultured in 2D on tissue culture dishes (* p < 0.05). These results indicate that the center of the glass adhesive surface of hemispherical cell aggregates which is expected to have the similar environment as the center of the spheroids can be directly observed through glass plates. In conclusion, Cell Dome would be useful as an evaluation platform for organized HepG2 cells.
Role of Decorin in the Lens and Ocular Diseases
Authors: Kubo Eri , Shibata Shinsuke , Shibata Teppei , Sasaki Hiroshi , Singh Dhirendra P.
Published: December 2022

Decorin is an archetypal member of the small leucine-rich proteoglycan gene family and is involved in various biological functions and many signaling networks, interacting with extra-cellular matrix (ECM) components, growth factors, and receptor tyrosine kinases. Decorin also modulates the growth factors, cell proliferation, migration, and angiogenesis. It has been reported to be involved in many ischemic and fibrotic eye diseases, such as congenital stromal dystrophy of the cornea, anterior subcapsular fibrosis of the lens, proliferative vitreoretinopathy, et al. Furthermore, recent evidence supports its role in secondary posterior capsule opacification (PCO) after cataract surgery. The expression of decorin mRNA in lens epithelial cells in vitro was found to decrease upon transforming growth factor (TGF)-β-2 addition and increase upon fibroblast growth factor (FGF)-2 addition. Wound healing of the injured lens in mice transgenic for lens-specific human decorin was promoted by inhibiting myofibroblastic changes. Decorin may be associated with epithelial–mesenchymal transition and PCO development in the lens. Gene therapy and decorin administration have the potential to serve as excellent therapeutic approaches for modifying impaired wound healing, PCO, and other eye diseases related to fibrosis and angiogenesis. In this review, we present findings regarding the roles of decorin in the lens and ocular diseases.
Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable
Authors: Bauer Mareike F. , Hildebrand Laura S. , Rosahl Marie-Charlotte , Erber Ramona , Schnellhardt Sören , Büttner-Herold Maike , Putz Florian , Ott Oliver J. , Hack Carolin C. , Fietkau Rainer , Distel Luitpold
Published: December 2022

Cell-in-cell (CIC) structures in breast cancer have so far been studied in a small inhomogeneous patient population, suggesting the prognostic importance of CIC. In the present study, we focused on CIC in early hormone-sensitive breast cancer. With in vitro co-culture experiments, we compared the homotypic phagocytic capacity of two breast cancer cell lines to that of primary human fibroblasts. Afterward, we studied 601 tissue specimens from 147 patients participating in an institutional accelerated partial breast irradiation (APBI) phase II trial. Both breast cancer cell lines performed non-professional phagocytosis at a higher rate than primary human fibroblasts. In this study cohort, 93.2% of the patients had T1 tumours, and 6.8% had T2 tumours. CIC was found in 61.2% of the patients, with a CIC rate ranging from <1/mm2 to 556.5/mm2 with a mean of 30.9/mm2 ± 68.4/mm2. CIC structures were prognostically favourable for local recurrence-free survival and disease-free survival. Regarding metastasis-free survival, CIC-positive patients had an unfavourable prognosis. Subgroup analysis indicated a correlation between a high proliferation index and high CIC rates. CIC had the highest prognostic value in young breast cancer patients (p = 0.004). With this study, we provide further evidence of CIC as a prognostic marker in breast cancer.
Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression
Authors: Yamada Kota , Saito Masafumi , Ando Masayuki , Abe Tomoki , Mukoyama Tomosuke , Agawa Kyosuke , Watanabe Akihiro , Takamura Shiki , Fujita Mitsugu , Urakawa Naoki , Hasegawa Hiroshi , Kanaji Shingo , Matsuda Takeru , Oshikiri Taro , Kakeji Yoshihiro , Yamashita Kimihiro
Published: December 2022

Obesity, a known risk factor for various types of cancer, reduces the number and function of cytotoxic immune cells in the tumor immune microenvironment (TIME). However, the impact of obesity on CD4+ T cells remains unclear. Therefore, this study aimed to clarify the impact of obesity on CD4+ T cells in the TIME. A tumor-bearing obese mouse model was established by feeding with 45% high-fat diet (HFD), followed by inoculation with a colon cancer cell line MC38. Tumor growth was significantly accelerated compared to that in mice fed a control diet. Tumor CD4+ T cells showed a significant reduction in number and an increased expression of programmed death-1 (PD-1), and decreased CD107a expression and cytokine such as IFN-γ and TNF-α production, indicating dysfunction. We further established CD4+ T cell-depleted HFD-fed model mice, which showed reduced tumor infiltration, increased PD-1 expression in CD8+ T cells, and obesity-induced acceleration of tumor growth in a CD4+ T cell-dependent manner. These findings suggest that the reduced number and dysfunction of CD4+ T cells due to obesity led to a decreased anti-tumor response of both CD4+ and CD8+ T cells to ultimately accelerate the progression of colorectal cancer. Our findings may elucidate the pathogenesis for poor outcomes of colorectal cancer associated with obesity.
Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease
Authors: Ho Hsin-Jung , Shirakawa Hitoshi
Published: December 2022

The kidney contains many mitochondria that generate ATP to provide energy for cellular processes. Oxidative stress injury can be caused by impaired mitochondria with excessive levels of reactive oxygen species. Accumulating evidence has indicated a relationship between oxidative stress and kidney diseases, and revealed new insights into mitochondria-targeted therapeutics for renal injury. Improving mitochondrial homeostasis, increasing mitochondrial biogenesis, and balancing mitochondrial turnover has the potential to protect renal function against oxidative stress. Although there are some reviews that addressed this issue, the articles summarizing the relationship between mitochondria-targeted effects and the risk factors of renal failure are still few. In this review, we integrate recent studies on oxidative stress and mitochondrial function in kidney diseases, especially chronic kidney disease. We organized the causes and risk factors of oxidative stress in the kidneys based in their mitochondria-targeted effects. This review also listed the possible candidates for clinical therapeutics of kidney diseases by modulating mitochondrial function.
Tissue Derivation and Biological Sex Uniquely Mediate Endothelial Cell Protein Expression, Redox Status, and Nitric Oxide Synthesis
Authors: Najjar Rami S. , Wong Brett J. , Feresin Rafaela G.
Published: December 2022

Human endothelial cells are routinely utilized in cardiovascular research to provide a translational foundation for understanding how the vascular endothelium functions in vivo. However, little attention has been given to whether there are sex specific responses in vitro. Similarly, it is unclear whether endothelial cells derived from distinct tissues behave in a homogenous manner. Herein, we demonstrate that marked sex differences exist within, and between, commonly utilized human primary endothelial cells from healthy donors, with respect to redox status, nitric oxide synthesis, and associated proteins that can mediate their expression. Further, we demonstrate that endothelial cells respond uniquely to inflammatory insult in a sex- and tissue origin-dependent manner. Our findings suggest sex and tissue derivation may need to be considered when studying endothelial cells in vitro as cells derived from distinct tissue and sexes may not behave interchangeably.
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma
Authors: Niazi Yasmeen , Paramasivam Nagarajan , Blocka Joanna , Kumar Abhishek , Huhn Stefanie , Schlesner Matthias , Weinhold Niels , Sijmons Rolf , De Jong Mirjam , Durie Brian , Goldschmidt Hartmut , Hemminki Kari , Försti Asta
Published: December 2022

Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline variants predisposing to MM. Genome-wide sequencing approaches in MM families have started to identify rare high-penetrance coding risk alleles. In addition, genome-wide association studies have discovered several common low-penetrance risk alleles, which are mainly located in the non-coding genome. Here, we further explored the genetic basis in familial MM within the non-coding genome in whole-genome sequencing data. We prioritized and characterized 150 upstream, 5′ untranslated region (UTR) and 3′ UTR variants from 14 MM families, including 20 top-scoring variants. These variants confirmed previously implicated biological pathways in MM development. Most importantly, protein network and pathway enrichment analyses also identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which have previously been established as important MM pathways.
Elabela: Negative Regulation of Ferroptosis in Trophoblasts via the Ferritinophagy Pathway Implicated in the Pathogenesis of Preeclampsia
Authors: Yang Huan , Zhang Xuemei , Ding Yubin , Xiong Hui , Xiang Shaojian , Wang Yang , Li Huanhuan , Liu Zheng , He Jie , Tao Yuelan , Yang Hongbing , Qi Hongbo
Published: December 2022

Preeclampsia is a leading contributor to increased maternal morbidity and mortality in the perinatal period. Increasing evidence demonstrates that ferroptosis is an essential mechanism for the pathogenesis of preeclampsia. Elabela is a novel small-molecule polypeptide, mainly expressed in embryonic and transplacental tissues, with an ability to promote cell proliferation and invasion. However, its specific regulatory mechanism in preeclampsia has not been completely elucidated. In this study, we first reveal an increased grade of ferroptosis accompanied by a downregulation of the expression of Elabela in preeclampsia placentas. We then confirm the presence of a ferroptosis phenotype in the placenta of the mouse PE-like model, and Elabela can reduce ferroptosis in the placenta and improve adverse pregnancy outcomes. Furthermore, we demonstrate that targeting Elabela alleviates the cellular dysfunction mediated by Erastin promoting increased lipid peroxidation in vitro. Subsequent mechanistic studies suggest that Elabela increases FTH1 levels by inhibiting the ferritinophagy pathway, and consequently chelates the intracellular labile iron pool and eventually arrests ferroptosis. In conclusion, Elabela deficiency exacerbates ferroptosis in the placenta, which is among the potential mechanisms in the pathogenesis of preeclampsia. Targeting the Elabela–ferritinophagy–ferroptosis signaling axis provides a new therapeutic intervention strategy to alleviate preeclampsia.